Friday, March 17, 2017

Alzheimer's and Marijuana-The Federal Block

I've blogged a couple of times recently about the fight against Alzheimer's disease.  Here's a recent story about research efforts stymied by federal law.  Big Alzheimer's research roadblock: Federal government was published by CNBC on March 9, 2017.   "Promising new research conducted last year at the Salk Institute for Biological Studies has shown that marijuana extracts may hold a key to treating Alzheimer's disease. The next step: To conduct tests on mice and, if the results are promising, move on to human trials. But Salk Institute researchers have run into a major hurdle, and not a scientific one: the federal government. The Salk Institute is based in La Jolla, California — a state that legalized marijuana last November — but it is a federally funded research institute."

The story reminds us that although marijuana use may be legal in several states, it's still not ok at the federal level-it's still a controlled substance. And when a research institute like Salk gets federal dollars for research, there's a problem.

So does this mean a dead end for marijuana/Alzheimer's research? Not necessarily. There is a path, but it won't be a quick or guaranteed one. "In order to acquire marijuana for further studies, the lab must first apply to the Drug Enforcement Agency, which carries out the application process jointly with the U.S. Department of Health and Human Services. The Salk researchers sent in their application in December...."  It takes several months for such a request to be approved.  The article discusses the costs of Alzheimer's disease  (which we have written about in prior posts)

The cost to the economy of caring for Alzheimer's and dementia patients was estimated to be about $236 billion in 2016. In 2015 a study funded by the National Institutes of Health estimated that the costs associated with late-stage dementia are greater than for any other disease.

During the last five years of a person with dementia's life, total health-care spending was more than a quarter of a million dollars per person ($287,038), about 57 percent greater than costs associated with death from other diseases, including cancer ($173,383) and heart disease ($175,136).

We all know how important it is to find an effective treatment (or even cure?) for Alzheimer's.  For now, the folks at Salk have to wait to hear if they can move forward.

BTW, those astute readers will notice the url for the story includes the phrase "major buzz kill." To  follow up, I'll close now with some my own pithy phrase,  "dude, serious bummer".  You insert your own pithy phrase here.....

http://lawprofessors.typepad.com/elder_law/2017/03/alzheimers-and-marijuana-the-federal-block.html

Cognitive Impairment, Consumer Information, Current Affairs, Dementia/Alzheimer’s, Health Care/Long Term Care, Science | Permalink

Comments

Post a comment